Although the use of intravesical immunotherapy for reducing tumor progression or as ... surgical mainstay for the diagnosis and treatment of Ta and T1 bladder cancer. After this procedure, the ...

A research team has developed an innovative nanomotor-based strategy to improve immunotherapy for bladder cancer. The study, ...

For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was ...

Neoadjuvant chemoimmunotherapy for muscle-invasive bladder cancer (MIBC) followed by risk-adapted therapy led to high rates of metastasis-free survival (MFS) and bladder preservation, according to ...

A new study suggests that a combination of radiation therapy and immune checkpoint inhibitors (ICIs) may offer a less ...

Cofactor Genomics announced today OncoPrism for colorectal, breast, bladder, and kidney cancer. This announcement follows ...

Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...

Tumor marker blood tests serve as a powerful diagnostic tool for many types of cancer. Learn more about how healthcare ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

You will need to see a healthcare provider for an accurate diagnosis and treatment. If untreated, a UTI or bladder infection can turn into a kidney infection. Kidney infections may lead to serious ...

Genome-scale metabolic reconstruction of urinary microbiome: Pathway for personalized medicine. Frequency and impact of a genome-wide homologous recombination deficiency signature (HRDsig+) on the ...